Monte Rosa Therapeutics Inc

GLUENASDAQ · USD
11.10USD-0.83 (-6.98%)
1310

Monte Rosa Therapeutics Inc (GLUE) Historical Volatility

GLUE 30-day historical volatility is 53%. This ranks in the 29th percentile of readings over the past year.

Read more

Tracking GLUE historical volatility helps you see how much Monte Rosa Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Monte Rosa Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor GLUE 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The GLUE 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Monte Rosa Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies.

Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Monte Rosa Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where GLUE HV is running hot, cold, or in line. Make the GLUE 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 30, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 30, 2026

See how volatility has moved over time

Track GLUE historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial